German ME/CFS Society Updates Website With Promising Therapies
The German Society for ME/CFS has updated its website with crucial information on therapies for the condition. Led by Prof. Dr. Carmen Scheibenbogen of Charité Berlin, recent research presents promising experimental approaches, while emphasizing the need for more clinical studies.
The new page discusses various treatments, including off-label medications for symptom relief. It highlights significant results from the international ME/CFS conference in May 2025, such as immunoadsorption, high-dose prednisolone, vericiguat, and hyperbaric oxygen therapy. Accompanying psychotherapy is also mentioned for psychological support.
The society warns against potentially harmful therapies based on false notions of the disease's origin. It emphasizes the importance of high-quality, placebo-controlled studies to assess the effectiveness of treatments. The topic of recovery, including spontaneous remissions, is addressed in relation to certain therapies. Pacing is highlighted as a central disease management strategy.
The updated website provides a comprehensive overview of current clinical research on healing therapies for ME/CFS. While recent findings offer hope, the society stresses the need for intensified clinical research to advance understanding and treatment of the condition.
Read also:
- Capella Nursing Students Gear Up for Crucial FPX 4050 Assessments
- Comprehensive Overview of Addressing Traumatic Brain Injuries (TBIs)
- Enhanced Health Services Provisioned by San Diego Academic Health Partnership Continues During COVID-19 and Beyond
- Vaccination drive targeting infants under 6 months old against bronchiolitis in the region of Andalucia
